Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators.

Falagario UG, Martini A, Wajswol E, Treacy PJ, Ratnani P, Jambor I, Anastos H, Lewis S, Haines K, Cormio L, Carrieri G, Rastinehad AR, Wiklund P, Tewari A.

Eur Urol Oncol. 2019 Sep 20. pii: S2588-9311(19)30141-5. doi: 10.1016/j.euo.2019.08.015. [Epub ahead of print]

PMID:
31548130
2.

Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study.

Rastinehad AR, Anastos H, Wajswol E, Winoker JS, Sfakianos JP, Doppalapudi SK, Carrick MR, Knauer CJ, Taouli B, Lewis SC, Tewari AK, Schwartz JA, Canfield SE, George AK, West JL, Halas NJ.

Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18590-18596. doi: 10.1073/pnas.1906929116. Epub 2019 Aug 26.

3.

Clinicopathological and survival analysis of clinically advanced papillary and chromophobe renal cell carcinoma.

Kaldany A, Paulucci DJ, Kannappan M, Beksac AT, Anastos H, Okhawere K, Sfakianos JP, Badani KK.

Urol Oncol. 2019 Oct;37(10):727-734. doi: 10.1016/j.urolonc.2019.05.008. Epub 2019 Jun 5.

PMID:
31174958
4.

Targeted Ablative Therapies for Prostate Cancer.

Winoker JS, Anastos H, Rastinehad AR.

Cancer Treat Res. 2018;175:15-53. doi: 10.1007/978-3-319-93339-9_2.

PMID:
30168116
5.

Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer.

Audenet F, Farkas AM, Anastos H, Galsky MD, Bhardwaj N, Sfakianos JP.

World J Urol. 2018 Nov;36(11):1741-1748. doi: 10.1007/s00345-018-2359-7. Epub 2018 Jun 2.

PMID:
29860605
6.

Cell death under epithelial-mesenchymal transition control in prostate cancer therapeutic response.

Begemann D, Anastos H, Kyprianou N.

Int J Urol. 2018 Apr;25(4):318-326. doi: 10.1111/iju.13505. Epub 2018 Jan 17. Review.

7.

Demographic and socioeconomic predictors of treatment delays, pathologic stage, and survival among patients with penile cancer: A report from the National Cancer Database.

Attalla K, Paulucci DJ, Blum K, Anastos H, Moses KA, Badani KK, Spiess PE, Sfakianos JP.

Urol Oncol. 2018 Jan;36(1):14.e17-14.e24. doi: 10.1016/j.urolonc.2017.09.014. Epub 2017 Oct 12.

PMID:
29031418
8.

Predicting Complications Following Robot-Assisted Partial Nephrectomy with the ACS NSQIP® Universal Surgical Risk Calculator.

Winoker JS, Paulucci DJ, Anastos H, Waingankar N, Abaza R, Eun DD, Bhandari A, Hemal AK, Sfakianos JP, Badani KK.

J Urol. 2017 Oct;198(4):803-809. doi: 10.1016/j.juro.2017.04.021. Epub 2017 Apr 9.

PMID:
28400189

Supplemental Content

Loading ...
Support Center